Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer

por Pershing, Nicole L.K., Yang, Chi-Fu J., Xu, MengMeng, Counter, Christopher M.
Publicado 2016

RalA and RalBP1 regulate mitochondrial fission at mitosis

por Kashatus, David F., Lim, Kian-Huat, Brady, Donita C., Pershing, Nicole L.K., Cox, Adrienne D., Counter, Christopher M.
Publicado 2011

Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis

por Le Roux, Özgün, Pershing, Nicole LK, Kaltenbrun, Erin, Newman, Nicole J, Everitt, Jeffrey I, Baldelli, Elisa, Pierobon, Mariaelena, Petricoin, Emanuel F, Counter, Christopher M
Publicado 2022